How many clinical trials are tracked of FOLFIRINOX?

10 trials are tracked, 1 with published results.

Mode

All Oncology Infectious Disease Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Primary Care & Family Medicine Gastroenterology Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Genetics & Precision Medicine Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Emergency Medicine Nephrology Urology Hematology Ophthalmology Dermatology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

FOLFIRINOX

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of FOLFIRINOX

10 trials tracked of FOLFIRINOX: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 99 citations.

10Trials tracked

1Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 3 1 Phase 2 8 Phase 1 1

Phase 3 Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas Completed · 99 cited
Phase 2 FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer Completed
Phase 2 Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer Completed
Phase 2 Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas Completed
Phase 2 A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients Completed
Phase 2 Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer Completed

Show 4 more trials

Phase 2 A Phase II Study of Neoadjuvant FOLFIRINOX Completed
Phase 2 First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem Completed
Phase 2 A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma Completed
Phase 1 Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.